End-of-day quote
Other stock markets
|
5-day change | 1st Jan Change | ||
20.41 CNY | -0.39% | +6.19% | +20.34% |
Jul. 01 | Certain A Shares of Beijing Winsunny Pharmaceutical CO.,LTD are subject to a Lock-Up Agreement Ending on 1-JUL-2024. | CI |
Jun. 19 | Zhejiang Nhu to Divest Subsidiary for 83 Million Yuan | MT |
Summary
- The company has a poor ESG score according to Refinitiv, which ranks companies by sector.
Strengths
- Its core activity has a significant growth potential and sales are expected to surge, according to Standard & Poor's' forecast. Indeed, those may increase by 48% by 2026.
- The company's EBITDA/Sales ratio is relatively high and results in high margins before depreciation, amortization and taxes.
- Margins returned by the company are among the highest on the stock exchange list. Its core activity clears big profits.
- The average price target of analysts who are interested in the stock has been strongly revised upwards over the last four months.
- The opinion of analysts covering the stock has improved over the past four months.
Weaknesses
- The company is in debt and has limited leeway for investment
- The company's enterprise value to sales, at 4.06 times its current sales, is high.
- Over the past twelve months, analysts' opinions have been revised negatively.
- The price targets of analysts who cover the stock differ significantly. This implies difficulties in evaluating the company and its business.
- Financial statements have repeatedly disappointed market stakeholders. Most often, they were below expectations.
Ratings chart - Surperformance
Chart ESG Refinitiv
Sector: Food Processing
1st Jan change | Capi. | Investor Rating | ESG Refinitiv | |
---|---|---|---|---|
+20.34% | 8.65B | D+ | ||
-0.67% | 7.18B | C- | ||
-18.41% | 4.82B | - | ||
-7.42% | 3.67B | B- | ||
-21.73% | 3.13B | D | ||
-16.84% | 1.14B | - | - | |
-29.29% | 1.08B | B+ | ||
-1.36% | 953M | C+ | ||
-15.47% | 863M | C+ | ||
-11.93% | 759M | - |
Financials
Valuation
Momentum
Consensus
Business Predictability
Environment
Governance
Controversy
Technical analysis
- Stock Market
- Equities
- 002001 Stock
- Ratings Zhejiang NHU Company Ltd.